Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo

Figure 1

Expression of miR-125b were assessed in EC cells by qRT-PCR and Northern blotting. A. Differential expression of miR-125b between type I and type II EC cells. Bars show mean ± SD. All experiments were repeated three times. *P < 0.01 vs. ishikawa, KLE, AN3CA. B. The results of Northern blotting show that the hybridized signal of the mature miR-125b in EC cells with ER negative was stronger than that in EC cells with ER positive.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us